Irenic Capital Management LP Invests $1.23 Million in The Cooper Companies, Inc. $COO

Irenic Capital Management LP purchased a new position in The Cooper Companies, Inc. (NASDAQ:COO) during the 4th quarter, HoldingsChannel reports. The fund purchased 15,000 shares of the medical device company’s stock, valued at approximately $1,229,000.

Several other institutional investors have also recently made changes to their positions in COO. Root Financial Partners LLC increased its stake in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares during the last quarter. Bell Investment Advisors Inc increased its stake in Cooper Companies by 106.3% in the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after acquiring an additional 219 shares during the last quarter. True Wealth Design LLC increased its stake in Cooper Companies by 484.8% in the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock valued at $38,000 after acquiring an additional 383 shares during the last quarter. Cromwell Holdings LLC increased its stake in Cooper Companies by 128.8% in the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after acquiring an additional 273 shares during the last quarter. Finally, Board of the Pension Protection Fund bought a new position in Cooper Companies in the fourth quarter valued at $41,000. Institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Wells Fargo & Company restated a “sell” rating and set a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. BNP Paribas Exane cut their price target on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research report on Monday, June 8th. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Stifel Nicolaus cut their price target on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Finally, Needham & Company LLC cut their price target on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $81.31.

Cooper Companies Stock Performance

Shares of COO opened at $65.05 on Thursday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The company has a 50-day simple moving average of $64.58 and a two-hundred day simple moving average of $74.10. The firm has a market capitalization of $12.69 billion, a PE ratio of 55.13, a price-to-earnings-growth ratio of 1.76 and a beta of 0.87.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same period last year, the business posted $0.96 earnings per share. Cooper Companies’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.